$0.4823
-0.01-2.03%
Last update: Nov 11, 7:08 AM
Filana Therapeutics Inc
FLNANASDAQ
Filana Therapeutics fell 84.5% from $3.11 to $0.48, behind the S&P 500's +9.8%. Its worst day was Dec 19 (−23.7%), and its low came Nov 5 at $0.45.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.22 beat the $-0.27 estimate on $0.00 revenue.
+4.8% · S&P 500 +0.1%
Filana Therapeutics closed at its highest level of the year, 9.0% above where the year started.
Story events cover the past 12 months · Times ET
+11.5% · S&P 500 +0.7%
Filana Therapeutics shares fell 23.7%, while the S&P 500 rose 0.9%.
−23.7%, the year's worst day · S&P 500 +0.9%
EPS of $-0.26 was reported on $0.00 revenue.
−6.7% · S&P 500 −1.5%
EPS of $-0.21 beat the $-0.23 estimate on $0.00 revenue.
−5.6% · S&P 500 −0.3%
EPS of $-0.18 beat the $-0.23 estimate on $0.00 revenue.
−1.7% · S&P 500 −1.5%
Filana Therapeutics shares rose 39.3%, while the S&P 500 fell 0.0%.
+39.3%, the year's best day, on 94M shares, the year's heaviest volume · S&P 500 0.0%
EPS of $-0.22 beat the $-0.24 estimate on $0.00 revenue.
−21.2% · S&P 500 −4.4%
Where it ended: a close of $0.48 on Nov 10, 2026. Up next: Q4 2026 earnings on Mar 11, 2027 (EPS est. $-0.27).
Nothing in the past 12 months.
All FLNA dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for FLNA and SPY from Benzinga historical bars. Not investment advice.
